[
  {
    "symbol": "LLY",
    "price": 458.7,
    "beta": 0.363732,
    "volAvg": 3032351,
    "mktCap": 435431536109,
    "lastDiv": 4.52,
    "range": "296.32-468.53",
    "changes": -5.8,
    "companyName": "Eli Lilly and Company",
    "currency": "USD",
    "cik": "0000059478",
    "isin": "US5324571083",
    "cusip": "532457108",
    "exchange": "New York Stock Exchange",
    "exchangeShortName": "NYSE",
    "industry": "Drug Manufacturersâ€”General",
    "website": "https://www.lilly.com",
    "description": "Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.",
    "ceo": "Mr. David A. Ricks",
    "sector": "Healthcare",
    "country": "US",
    "fullTimeEmployees": "39000",
    "phone": "317 276 2000",
    "address": "Lilly Corporate Center",
    "city": "Indianapolis",
    "state": "IN",
    "zip": "46285",
    "dcfDiff": 23.2584,
    "dcf": 365.358,
    "image": "https://financialmodelingprep.com/image-stock/LLY.png",
    "ipoDate": "1972-06-01",
    "defaultImage": false,
    "isEtf": false,
    "isActivelyTrading": true,
    "isAdr": false,
    "isFund": false
  }
]